🌿 Innovative Industrial Properties ($IIPR): $1M Insider Buy, 14.7% Yield & the Biotech Pivot 🌿🧪
Innovative Industrial Properties ($IIPR) is stirring up an extraordinary investment debate. Its executive chairman just invested $1 million in preferred shares, the common stock offers an indicated dividend yield near 14.7%, institutional ownership approaches 80%, and short interest exceeds 15%. Meanwhile, a $270 million life sciences investment could reshape this battered cannabis REIT. Is IIPR an overlooked income-and-recovery opportunity—or a dividend trap? We examine the evidence through the FunStock Method™. FunStock Index™: 7.65/10. 🌿🧪
🏦 Kayne Anderson BDC (KBDC): A $5.2M Insider Buy, 12.3% Yield—and the BDC Trap 💰⚡
Kayne Anderson BDC Chairman Jim Robo just put $5.2 million behind KBDC near $13. Add a 12.3% yield, deep discount to NAV and covered dividend, and the stock looks irresistible—until you examine NAV erosion, leverage and private-credit risk.
Alpha Metallurgical Resources (AMR) Stock Analysis: Should You Follow a $26 Million Insider Buying Spree?
Alpha Metallurgical Resources (NYSE: AMR) looks compelling on paper: legendary insider buying, aggressive buybacks and a pristine balance sheet. But commodity cycles, recent losses and long-term industry headwinds suggest caution may still be the wiser investment.
🦾 IperionX (IPX): The Titanium Disruptor Powering America’s Supply Chain Revolution
IperionX (IPX) is turning from a science experiment into a 24/7 titanium production story—with insiders buying, institutions circling, and the U.S. government backing the mission. The upside looks massive. So do the risks.
Alexandria Real Estate (ARE): The Life Science “Dr. Frankenstein” Pivot — Rebuilding the Lab from the Floor Up
Alexandria Real Estate (ARE) is the king of life science labs—and one of the most punished REITs of the last five years. After a brutal dividend cut, asset write-downs, and a 75% drawdown, the founder just bought $1.3M of stock and the company is buying back shares. Is this a broken experiment—or a classic cycle-bottom setup?
We Were Bullish on Barrick Mining 10 Months Ago: It’s Nearly Tripled Since — Now Valuation Is Stretched
Barrick Mining nearly tripled after our bullish call last year. The business is strong, gold is loved — but valuation is stretched. Time to pause, not chase.
Paulson Buys International Tower Hill Mines: Gold, Antimony & a $115M Fortress Bet
THM isn’t a stock — it’s a vault. With Paulson anchoring a $115M raise, gold-price convexity, and an antimony wildcard, International Tower Hill Mines is one of the most fascinating optionality plays of 2026.
$236.4M for a Portrait? Gustav Klimt Says ‘Hold My Gold Leaf’
Gustav Klimt’s Portrait of Elisabeth Lederer sold for a jaw-dropping $236.4M — the highest modern-art price ever and the second priciest artwork ever at auction. Bidding battles, art-world drama, gold leaf magic, and a portrait with more history than a Bloomberg terminal… all inside.
Coinbase (COIN): The Everything-Exchange That Institutions Keep Swiping Right On
Institutions keep swiping right on Coinbase ($COIN). Moat or mirage? We break down Base, USDC rails, derivatives, and risks—TL;DR included. Coinbase isn’t just an exchange—it’s building the on-chain OS. If the thesis plays out, premium multiples make sense. If not… bring Dramamine.
CEO Buys More Upexi: Should You Speculate Too... or Just Diversify and HODL?
Insiders are buying. The company’s loading up on Solana. And tokenized equity is on the table. Upexi (UPXI) isn’t your average consumer brand—it’s staking its future (literally) in crypto. Should you diversify… or duck?